IL-22 promotes fibroblast-mediated wound repair in the skin

Journal of Investigative Dermatology

Volumn 133, Issue 5, 2013, Pages 1321-1329

  McGee, Heather M ^a,b   Schmidt, Barbara A ^a   Booth, Carmen J ^a   Yancopoulos, George D ^c   Valenzuela, David M ^c   Murphy, Andrew J ^c   Stevens, Sean ^c,d   Flavell, Richard A ^b   Horsley, Valerie ^a  

^a YALE UNIVERSITY   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c REGENERON PHARMACEUTICALS INC   (United States)

^d Research AbLexis LLC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 22;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; EXTRACELLULAR MATRIX; FIBROBLAST; FULL THICKNESS SKIN GRAFT; GENE EXPRESSION; IMMUNOCOMPETENT CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; WOUND HEALING;

EID: 84876681730     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2012.463     Document Type: Article

References (56)

1. Barisic-Dujmovic T, Boban I, Clark SH (2010) Fibroblasts/myofibroblasts that participate in cutaneous wound healing are not derived from circulating progenitor cells. J Cell Physiol 222:703-12
2. Barrientos S, Stojadinovic O, Golinko MS et al. (2008) Growth factors and cytokines in wound healing. Wound Repair Regen 16:585-601
3. Boniface K, Bernard FX, Garcia M et al. (2005) IL-22 inhibits epidermal differentiation and induces proinflammatory gene expression and migration of human keratinocytes. J Immunol 174:3695-702
4. Cella M, Fuchs A, Vermi W et al. (2009) A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity. Nature 457:722-5
5. Cupedo T, Crellin NK, Papazian N et al. (2009) Human fetal lymphoid tissue-inducer cells are interleukin 17-producing precursors to RORC + CD127+ natural killer-like cells. Nat Immunol 10:66-74
6. Darby I, Skalli O, Gabbiani G (1990) Alpha-smooth muscle actin is transiently expressed by myofibroblasts during experimental wound healing. Lab Invest 63:21-9
7. Dorschner RA, Pestonjamasp VK, Tamakuwala S et al. (2001) Cutaneous injury induces the release of cathelicidin anti-microbial peptides active against group A Streptococcus. J Invest Dermatol 117:91-7
8. Dudakov JA, Hanash AM, Jenq RR et al. (2012) Interleukin-22 drives endogenous thymic regeneration in mice. Science 336:91-5
9. Dumoutier L, Leemans C, Lejeune D et al. (2001) Cutting edge: STAT activation by IL-19, IL-20 and mda-7 through IL-20 receptor complexes of two types. J Immunol 167:3545-9
10. Dumoutier L, Lejeune D, Hor S et al. (2003) Cloning of a new type II cytokine receptor activating signal transducer and activator of transcription (STAT)1, STAT2 and STAT3. Biochem J 370:391-6
11. Eming SA, Krieg T, Davidson JM (2007) Inflammation in wound repair: molecular and cellular mechanisms. J Invest Dermatol 127:514-25
12. Eyerich S, Eyerich K, Pennino D et al. (2009) Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling J Clin Invest 119:3573-85
13. Festa E, Fretz J, Berry R et al. (2011) Adipocyte lineage cells contribute to the skin stem cell niche to drive hair cycling. Cell 146:761-71
14. Gabbiani G, Le Lous M, Bailey AJ et al. (1976) Collagen and myofibroblasts of granulation tissue. A chemical, ultrastructural and immunologic study. Virchows Arch B Cell Pathol 21:133-45
15. Geboes L, Dumoutier L, Kelchtermans H et al. (2009) Proinflammatory role of the Th17 cytokine interleukin-22 in collagen-induced arthritis in C57BL/6 mice. Arthritis Rheum 60:390-5
16. Goto M, Murakawa M, Kadoshima-Yamaoka K et al. (2009) Murine NKT cells produce Th17 cytokine interleukin-22. Cell Immunol 254:81-4
17. Horsley V, Aliprantis AO, Polak L et al. (2008) NFATc1 balances quiescence and proliferation of skin stem cells. Cell 132:299-310
18. Jun JI, Lau LF (2010a) Cellular senescence controls fibrosis in wound healing. Aging (Albany NY) 2:627-31
19. Jun JI, Lau LF (2010b) The matricellular protein CCN1 induces fibroblast senescence and restricts fibrosis in cutaneous wound healing. Nat Cell Biol 12:676-85
20. Kagami S, Rizzo HL, Lee JJ et al. (2010) Circulating Th17, Th22, and Th1 cells are increased in psoriasis. J Invest Dermatol 130:1373-83
21. Kim KW, Kim HR, Park JY et al. (2012) IL-22 promotes osteoclastogenesis in rheumatoid arthritis through induction of RANKL in human synovial fibroblasts. Arthritis Rheum 64:1015-23
22. Koivukangas V, Kallionen M, Karvonen J et al. (1995) Increased collagen synthesis in psoriasis in vivo. Arch Dermatol Res 287:171-5
23. Kong X, Feng D, Wang H et al. (2012) Interleukin-22 induces hepatic stellate cell senescence and restricts liver fibrosis. Hepatology 56:1150-9
24. Kotenko SV (2002) The family of IL-10-related cytokines and their receptors: related, but to what extent? Cytokine Growth Factor Rev 13:223-40
25. Kotenko SV, Izotova LS, Mirochnitchenko OV et al. (2001) Identification of the functional interleukin-22 (IL-22) receptor complex: the IL-10R2 chain (IL-10Rbeta) is a common chain of both the IL-10 and IL-22 (IL-10-related T cell-derived inducible factor, IL-TIF) receptor complexes. J Biol Chem 276:2725-32
26. Kunz S, Wolk K, Witte E et al. (2006) Interleukin (IL)-19, IL-20 and IL-24 are produced by and act on keratinocytes and are distinct from classical ILs. Exp Dermatol 15:991-1004
27. Lejeune D, Dumoutier L, Constantinescu S et al. (2002) Interleukin-22 (IL-22) activates the JAK/STAT, ERK, JNK, and p38 MAP kinase pathways in a rat hepatoma cell line. Pathways that are shared with and distinct from IL-10. J Biol Chem 277:33676-82
28. Liang SC, Tan XY, Luxenberg DP et al. (2006) Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J Exp Med 203:2271-9
29. Liu S, Xu SW, Blumbach K et al. (2010) Expression of integrin beta1 by fibroblasts is required for tissue repair in vivo. J Cell Sci 123:3674-82
30. Lowes MA, Kikuchi T, Fuentes-Duculan J et al. (2008) Psoriasis vulgaris lesions contain discrete populations of Th1 and Th17 T cells. J Invest Dermatol 128:1207-11
31. Ma HL, Liang S, Li J et al. (2008) IL-22 is required for Th17 cell-mediated pathology in a mouse model of psoriasis-like skin inflammation. J Clin Invest 118:597-607
32. Martin B, Hirota K, Cua DJ et al. (2009) Interleukin-17-producing gammadelta T cells selectively expand in response to pathogen products and environmental signals. Immunity 31:321-30
33. Montesano R, Orci L (1988) Transforming growth factor beta stimulates collagen-matrix contraction by fibroblasts: implications for wound healing. Proc Natl Acad Sci USA 85:4894-7
34. O'Connor W, Kamanaka M, Booth CJ et al. (2009) A protective function for interleukin 17A in T cell-mediated intestinal inflammation. Nat Immunol 10:603-9
35. Qiu C, Coutinho P, Frank S et al. (2003) Targeting connexin43 expression accelerates the rate of wound repair. Curr Biol 13:1697-703
36. Radaeva S, Sun R, Pan HN et al. (2004) Interleukin 22 (IL-22) plays a protective role in T cell-mediated murine hepatitis: IL-22 is a survival factor for hepatocytes via STAT3 activation. Hepatology 39:1332-42
37. Sasaki JR, Zhang Q, Schwacha MG (2011) Burn induces a Th-17 inflammatory response at the injury site. Burns 37:646-51
38. Sawicki G, Marcoux Y, Sarkhosh K et al. (2005) Interaction of keratinocytes and fibroblasts modulates the expression of matrix metalloproteinases-2 and-9 and their inhibitors. Mol Cell Biochem 269:209-16
39. Sekikawa A, Fukui H, Suzuki K et al. (2010) Involvement of the IL-22/REG Ialpha axis in ulcerative colitis. Lab Invest 90:496-505
40. Snyder M, Huang XY, Zhang JJ (2008) Identification of novel direct Stat3 target genes for control of growth and differentiation. J Biol Chem 283:3791-8
41. Steenvoorden MM, Tolboom TC, van der Pluijm G et al. (2006) Transition of healthy to diseased synovial tissue in rheumatoid arthritis is associated with gain of mesenchymal/fibrotic characteristics. Arthritis Res Ther 8:R165
42. Takatori H, Kanno Y, Watford WT et al. (2009) Lymphoid tissue inducer-like cells are an innate source of IL-17 and IL-22. J Exp Med 206:35-41
43. Tammela T, Zarkada G, Wallgard E et al. (2008) Blocking VEGFR-3 suppresses angiogenic sprouting and vascular network formation. Nature 454: 656-60
44. Truchetet ME, Brembilla NC, Montanari E et al. (2011) Increased frequency of circulating Th22 in addition to Th17 and Th2 lymphocytes in systemic sclerosis: association with interstitial lung disease. Arthritis Res Ther 13:R166
45. Tumbar T, Guasch G, Greco V et al. (2004) Defining the epithelial stem cell niche in skin. Science 303:359-63
46. Valenzuela DM, Murphy AJ, Frendewey D et al. (2003) High-throughput engineering of the mouse genome coupled with high-resolution expression analysis. Nat Biotechnol 21:652-9
47. Van Vliet E, Melis M, Van Ewijk W (1984) Monoclonal antibodies to stromal cell types of the mouse thymus. Eur J Immunol 14:524-9
48. Werner S, Grose R (2003) Regulation of wound healing by growth factors and cytokines. Physiol Rev 83:835-70
49. Wolk K, Kunz S, Witte E et al. (2004) IL-22 increases the innate immunity of tissues. Immunity 21:241-54
50. Wolk K, Witte E, Wallace E et al. (2006) IL-22 regulates the expression of genes responsible for antimicrobial defense, cellular differentiation, and mobility in keratinocytes: a potential role in psoriasis. Eur J Immunol 36:1309-23
51. Xie MH, Aggarwal S, Ho WH et al. (2000) Interleukin (IL)-22, a novel human cytokine that signals through the interferon receptor-related proteins CRF2-4 and IL-22R. J Biol Chem 275:31335-9
52. Yamamoto-Furusho JK, Miranda-Pérez E, Fonseca-Camarillo G et al. (2010) Colonic epithelial upregulation of interleukin 22 (IL-22) in patients with ulcerative colitis. Inflamm Bowel Dis 16:1823
53. Zenewicz LA, Yancopoulos GD, Valenzuela DM et al. (2007) Interleukin-22 but not interleukin-17 provides protection to hepatocytes during acute liver inflammation. Immunity 27:647-59
54. Zenewicz LA, Yancopoulos GD, Valenzuela DM et al. (2008) Innate and adaptive interleukin-22 protects mice from inflammatory bowel disease. Immunity 29:947-57
55. Zhang W, Dang E, Shi X et al. (2012) The pro-inflammatory cytokine IL-22 up-regulates keratin 17 expression in keratinocytes via STAT3 and ERK1/2. PLoS One 7:e40797
56. Zheng Y, Danilenko DM, Valdez P et al. (2007) Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. Nature 445:648-51